LILLY 4165
Generic Name: raloxifene
Pill imprint LILLY 4165 has been identified as Evista 60 mg.
Evista is used in the treatment of osteoporosis; prevention of osteoporosis; breast cancer, prevention and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy.
Evista 60 mg is not subject to the Controlled Substances Act.
See also related documents.
Evista Images
- Generic Name:
- raloxifene
- Imprint:
-
LILLY 4165
- Strength:
- 60 mg
- Color:
- White
- Size:
- 12.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- carnauba wax
crospovidone
hypromelloses
lactose monohydrate
lactose anhydrous
magnesium stearate
polyethylene glycol
povidone
titanium dioxide
polysorbate 80
propylene glycol
- Drug Class:
- Hormones/antineoplastics
Selective estrogen receptor modulators - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Lilly, Eli and Company
- National Drug Code (NDC):
- 00002-4165
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-4628 | A S Medication Solutions LLC (repackager) |
| 54868-4170 | Physicians Total Care Inc (repackager) |
| 57866-0002 | Direct Dispensing Inc (repackager) |
| 55289-0266 | PDRX Pharmaceuticals Inc (repackager) |
| 49999-0458 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.


